S-1 combined preoperative neoadjuvant Multimodality therapy with Radiation and Irinotecan for locally advanced rectal cancer
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2019
Price : $35 *
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan
- Indications Rectal cancer
- Focus Therapeutic Use
- Acronyms SAMRAI2
- 07 Jan 2019 Status changed from active, no longer recruiting to completed.
- 06 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 01 Oct 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.